Key Takeaways:
JD Health International Inc. (6618.HK) reported first-quarter operating profit surged 70% year-on-year to 1.82 billion yuan, driven by a steady expansion in sales.
The healthcare arm of Chinese e-commerce giant JD.com saw its revenue climb 17 percent from a year earlier to 19.47 billion yuan for the three months ended March 31, according to a preliminary announcement on Sunday. The company did not disclose net profit or earnings per share figures.
The significant profit acceleration, which far outpaced revenue growth, suggests the company is achieving greater operational efficiency and improving margins. The performance offers a strong start to the year for the online health provider.
The results position JD Health as a key beneficiary of the ongoing shift to online pharmacy and healthcare services in China. Investors will watch for the release of the company's full, detailed financial statements for further details on segment performance and any forward-looking guidance from management.
This article is for informational purposes only and does not constitute investment advice.
